Technology appraisal guidance Published: 27 March 2000 nice.org.uk/guidance/ta1

Similar documents
Guidance on the use of gemcitabine for the treatment of pancreatic cancer

Technology appraisal guidance Published: 23 August 2000 nice.org.uk/guidance/ta10

Technology appraisal guidance Published: 15 March 2002 nice.org.uk/guidance/ta34

Technology appraisal guidance Published: 23 January 2001 nice.org.uk/guidance/ta20

Technology appraisal guidance Published: 26 September 2001 nice.org.uk/guidance/ta29

Guidance on the Use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease

Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia

Guidance on the use of paclitaxel in the treatment of ovarian cancer

Technology appraisal guidance Published: 26 September 2002 nice.org.uk/guidance/ta48

Maxillofacial Patient Information Leaflet

Putting NICE guidance into practice

Technology appraisal guidance Published: 4 October 2002 nice.org.uk/guidance/ta49

Extracorporeal shockwave therapy for refractory Achilles tendinopathy

Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis

Translaryngeal tracheostomy

Infracoccygeal sacropexy using mesh for uterine prolapse repair

Technology appraisal guidance Published: 26 April 2003 nice.org.uk/guidance/ta59

Low back pain and sciatica in over 16s NICE quality standard

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Haemorrhoidal artery ligation

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE. Final Appraisal Determination. Continuous subcutaneous insulin infusion for diabetes

Medical technologies guidance Published: 2 October 2018 nice.org.uk/guidance/mtg39

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Unstable angina and NSTEMI

Clinical guideline Published: 27 June 2012 nice.org.uk/guidance/cg143

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta500

Uterine artery embolisation for treating adenomyosis

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

London Intermediate Minor Oral Surgery Referral Form PATIENT DETAILS

Technology appraisal guidance Published: 23 August 2006 nice.org.uk/guidance/ta105

Clinical guideline Published: 23 March 2011 nice.org.uk/guidance/cg118

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Technology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516

Rituximab for aggressive non- Hodgkin's lymphoma

Choosing and delivering ering interventions entions for

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Third molar (wisdom) teeth

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Guidance on the use of electroconvulsive therapy

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Clinical guideline Published: 17 March 2008 nice.org.uk/guidance/cg64

NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56

Human growth hormone (somatropin) in adults with growth hormone deficiency

Technology appraisal guidance Published: 26 July 2017 nice.org.uk/guidance/ta459

Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management

Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)

Technology Appraisal Guidance - No. 49. Guidance on the use of ultrasound locating devices for placing central venous catheters

Smoking cessation interventions and services

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

South East Coast Operational Delivery Network. Critical Care Rehabilitation

Technology appraisal guidance Published: 20 December 2017 nice.org.uk/guidance/ta496

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Technology appraisal guidance Published: 28 November 2018 nice.org.uk/guidance/ta547

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta465

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta499

Putting NICE guidance into practice

Referral of Patients. to the. Community Dental Referral Service. Hillingdon

Alcohol interventions in secondary and further education

The effects of NICE guidelines on the management of third molar teeth

Patient information leaflet about Lower Wisdom Teeth (3 rd Molars)

Technology appraisal guidance Published: 25 July 2007 nice.org.uk/guidance/ta123

Minor Oral Surgery Service

Technology appraisal guidance Published: 26 April 2017 nice.org.uk/guidance/ta442

INTRODUCTION TO GUARDIAN CLINICAL POLICY

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Technology appraisal guidance Published: 27 July 2005 nice.org.uk/guidance/ta92

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta472

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

Technology appraisal guidance Published: 21 November 2018 nice.org.uk/guidance/ta546

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Prostate artery embolisation for benign prostatic hyperplasia

Technology appraisal guidance Published: 21 February 2018 nice.org.uk/guidance/ta507

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

There are three referral categories used in the dental referral system:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Clinical guideline Published: 23 May 2012 nice.org.uk/guidance/cg140

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Technology appraisal guidance Published: 12 July 2017 nice.org.uk/guidance/ta456

Technology appraisal guidance Published: 8 November 2017 nice.org.uk/guidance/ta487

Technology appraisal guidance Published: 27 March 2019 nice.org.uk/guidance/ta572

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Clinical guideline Published: 11 August 2010 nice.org.uk/guidance/cg106

Clinical guideline Published: 23 February 2009 nice.org.uk/guidance/cg81

Technology appraisal guidance Published: 30 October 2002 nice.org.uk/guidance/ta52

Technology appraisal guidance Published: 7 February 2018 nice.org.uk/guidance/ta505

Technology appraisal guidance Published: 6 September 2017 nice.org.uk/guidance/ta476

Technology appraisal guidance Published: 16 May 2018 nice.org.uk/guidance/ta520

Technology appraisal guidance Published: 22 September 2010 nice.org.uk/guidance/ta200

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Transcription:

Guidance on the Extraction of Wisdom Teeth Technology appraisal guidance Published: 27 March 2000 nice.org.uk/guidance/ta1 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

Your responsibility The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance are at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Commissioners and/or providers have a responsibility to provide the funding required to enable the guidance to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Page 2 of

Contents 1 Guidance... 4 2 Clinical Need and Practice... 5 3 Evidence... 6 4 Implications for the NHS... 7 5 Further research... 8 6 Implementation... 9 7 Clinical Audit Advice... 10 8 Review of Guidances... 11 Appendix A. Appraisal Committee Members... 12 Appendix B. Documentation and Opinion Available to the Appraisal Committee... 14 Appendix C. Wisdom Teeth Removal Patient Notes... 15 What is NICE guidance?... 15 What are Wisdom Teeth and why are they operated on?... 15 What do NICE recommend about the removal of Wisdom Teeth?... 15 What should I do?... 17 Will NICE review its guidance?... 17 Further information... 17 Changes after publication... 18 About this guidance... Page 3 of

1 Guidance 1.1 The practice of prophylactic removal of pathology-free impacted third molars should be discontinued in the NHS. 1.2 The standard routine programme of dental care by dental practitioners and/or paraprofessional staff, need be no different, in general, for pathology free impacted third molars (those requiring no additional investigations or procedures). 1.3 Surgical removal of impacted third molars should be limited to patients with evidence of pathology. Such pathology includes unrestorable caries, nontreatable pulpal and/or periapical pathology, cellulitis, abcess and osteomyelitis, internal/external resorption of the tooth or adjacent teeth, fracture of tooth, disease of follicle including cyst/tumour, tooth/teeth impeding surgery or reconstructive jaw surgery, and when a tooth is involved in or within the field of tumour resection. 1.4 Specific attention is drawn to plaque formation and pericoronitis. Plaque formation is a risk factor but is not in itself an indication for surgery. The degree to which the severity or recurrence rate of pericoronitis should influence the decision for surgical removal of a third molar remains unclear. The evidence suggests that a first episode of pericoronitis, unless particularly severe, should not be considered an indication for surgery. Second or subsequent episodes should be considered the appropriate indication for surgery. Page 4 of

2 Clinical Need and Practice 2.1 Permanent molar teeth normally erupt from the age of six onwards, with the third molars (wisdom teeth) being the last to erupt, usually between the ages of eighteen and twenty four years. Wisdom teeth may erupt normally into correct dental alignment and function or conversely develop in non- or minimally functional positions. Impaction occurs when there is prevention of complete eruption due to lack of space, obstruction or development in an abnormal position. This may result in a tooth erupting partially or not at all. Wisdom teeth can also be impacted, either erupting partially or not at all. Impaction may be associated with pathological changes including pericoronitis, an increased risk of caries and periodontal disease in adjacent teeth, and orthodontic problems in later life. 2.2 Removal of wisdom teeth is one of the most common surgical procedures performed in the UK. Current practice includes both the removal of impacted third molars causing pathological changes as well as the early prophylactic removal of pathology-free impacted third molars. Wide variations in the rates of this latter procedure across the country, which suggest that in the past, up to 44% of wisdom teeth removals and prophylactic surgery may have been inappropriate, have been reported. However, in recent years, changes in the practice of removal of wisdom teeth may have taken place in response to Faculty of Dental Surgery, Royal College of Surgeon's guidelines. [1] Even so, some 22% of procedures may still be inappropriate. In 94/95 there were approximately 36,000 inpatient and 60,000 day case admissions in England. More recent figures (98/99) for Wales indicate that there were up to 3000 procedures. It is estimated that the total cost to the NHS in England and Wales of wisdom teeth extractions is up to 12 million per year. [1] Current clinical practice and parameters of care: The management of patients with third molar teeth. Faculty of Dental Surgery of the Royal College of Surgeons September 97. Page 5 of

3 Evidence 3.1 There is no reliable research evidence to support a health benefit to patients from the prophylactic removal of pathology-free impacted third molar teeth. 3.2 Every procedure for the removal of an impacted third molar carries risk for the patient, including temporary or permanent nerve damage, alveolar osteitis, infection and haemorrhage as well as temporary local swelling, pain and restricted mouth opening. There are also risks associated with the need for general anaesthesia in some of these procedures, including rare and unpredictable death. Such patients are therefore being exposed to the risk of undertaking a surgical procedure unnecessarily. 3.3 A list of the source documentation and opinion made available to the Appraisal Committee is attached as Appendix B. Page 6 of

4 Implications for the NHS 4.1 Given the uncertainty in current rates of prophylactic removal of pathology-free impacted third molars, it is difficult to precisely quantify the budget impact of discontinuation of this practice. However, based on 94/95 data, this could result in an opportunity to release capacity in the specialty with a value of up to 5 million (NHS in England & Wales) 4.2 The number of patients waiting for this operation, in England and Wales might change, if waiting lists are reviewed using this guidance. Page 7 of

5 Further research 5.1 There are two ongoing randomised controlled trials (in the United States and in Denmark) comparing prophylactic extraction of wisdom teeth with management by deliberate retention. The results of these trials will be reviewed by the Institute to establish whether they have a material impact on this guidance. Page 8 of

6 Implementation 6.1 NHS trusts and dental practitioners should review their current practice against this guidance and use the audit advice set out below to prospectively collect data on individual practitioners' performance. 6.2 The position of individual patients, currently scheduled for extraction of wisdom teeth, should be reviewed. This may be possible through a case note review but there may be circumstances in which patients will need to be invited to attend a review clinic. 6.3 The patient information, attached to this guidance as Appendix C, can be drafted into local information leaflets and could also be used to help inform patients, if it is necessary to issue invitations to attend review clinics. Page 9 of

7 Clinical Audit Advice 7.1 To enable dental practitioners to audit their own compliance with this guidance, it is recommended that all those who perform wisdom teeth extraction, should routinely record the indication for surgery and the diagnosis (see 1.3) 7.2 It is recommended that this information be incorporated into manual recording systems and consideration given to the establishment of appropriate categories in electronic record keeping systems in general practices and hospitals. 7.3 Prospective clinical audit programmes should record the proportion of extractions adhering to the criteria described in this guidance. Such programmes are likely to be more effective in improving patient care when they form part of the organisation's formal clinical governance arrangements and where they are linked to specific post-graduate activities. Page 10 of

8 Review of Guidances 8.1 Information on the review of the guidance on this technology is available on the NICE website. Andrew Dillon Chief Executive March 2000 Page 11 of

Appendix A. Appraisal Committee Members Professor R. L.. Akehurst Dean, School of Health Related Research Sheffield University Professor David Barnett (Chairman) Professor of Clinical Pharmacology University of Leicester Professor Sir Colin Berry Professor of Morbid Anatomy St Bartholomew's and Royal London School of Medicine Professor Martin Buxton Director of Health Economics Research Group Brunel University Professor Yvonne Carter Professor of General Practice and Primary Care St Bartholomew's and Royal London School of Medicine Dr Karl Claxton Lecturer in Economics University of York Professor Duncan Colin-Jones Professor of Gastroenterology University of Southampton Dr Nicky Cullum Reader in Health Studies University of York Mr Chris Evennett Chief Executive Mid-Hampshire Primary Care Group Ms Jean Gaffin Formerly Executive Director National Council for Hospice and Specialist Palliative Care Service Mrs Sue Gallagher Chief Executive Merton, Sutton and Wandsworth Health Authority Dr Trevor Gibbs International Medical Operations Director GlaxoWellcome R&D Ltd Page 12 of

Dr Sheila Bird MRC Biostatistics Unit, Cambridge Mr John Goulston Director of Finance The Royal Free Hampstead NHS Trust Professor Philip Home Professor of Diabetes Medicine University of Newcastle Dr Terry John General Practitioner The Firs, London Dr Diane Ketley Clinical Governance Programme Leader, Leicester Royal Infirmary Dr Mayur Lakhani General Practitioner, Highgate Surgery, Leicester and Lecturer, University of Leicester Mr M Mughal Consultant Surgeon Chorley and South Ribble NHS Trust Mr James Partridge Chief Executive Changing Faces Professor Philip Routledge Professor of Clinical Pharmacology University of Wales Professor Andrew Stevensens Professor of Public Health University of Birmingham Page 13 of

Appendix B. Documentation and Opinion Available to the Appraisal Committee i) The following documentation was made available to the Appraisal Committee: a) Assessment Report Song F, O'Meara S, Wilson P, Kliejnen J, Golder S. The effectiveness and cost effectiveness of the prophylactic removal of wisdom teeth. NHS Centre for Reviews and Dissemination, University of York; November 99; b) ) Professional/Specialist group submissions; The Faculty of Dental Surgery, The Royal College of Surgeons of England. Birmingham Dental Hospital British Dental Association British Medical Association Dentistry 2000 The British Dental Industry Association Royal College of Nursing ii) The following experts were invited to make submissions to the Committee: a) Mr David Kramer, Dental Surgeon & Principle, Marchgate Dental Practice. b) Professor Robin Seymour, Head of Department of Restorative Surgery, Dental School, Newcastle upon Tyne. c) Mr John Lowry, the Department of Maxillofacial Surgery at the Royal Bolton Hospital. Page 14 of

Appendix C. Wisdom Teeth Removal Patient Notes What is NICE guidance? The National Institute for Clinical Excellence (NICE) is a part of the NHS. It has a team of experts who produce guidance for both the NHS and patients on medicines, medial equipment and clinical procedures. When the Institute evaluates these things, it is called an appraisal. Each appraisal takes around 12 months to complete and involves the manufacturers of the technology, patient groups and professional organisations. NICE was asked to look at wisdom teeth removal and provide guidance to the NHS which will help dentists and surgeons decide when wisdom teeth should be removed. What are Wisdom Teeth and why are they operated on? Adult teeth normally come through from the age of 6 upwards, with the wisdom teeth being the last to arrive (usually between the ages of 18 & 24 years). Sometimes, as wisdom teeth come through they cause problems. The term used to describe wisdom teeth that don't come through normally is impacted wisdom teeth. Two reasons for this are a lack of space, or other teeth being in the way. For most people, impacted wisdom teeth cause no problems at all, but some people can suffer problems such as inflammation of the surrounding gum, a higher risk of tooth decay, gum disease in other teeth, and possibly problems with teeth in later life. Removal of wisdom teeth is one of the most common operations carried out in the UK. Impacted wisdom teeth have sometimes been removed whether or not they were causing problems. There is no reliable evidence to suggest that operating on impacted wisdom teeth that are not causing problems has any benefit for the patient. In fact every operation has some risk. What do NICE recommend about the removal of Wisdom Teeth? Based on the evidence, NICE has recommended to the NHS that: Page 15 of

1. Impacted wisdom teeth that are free from disease (healthy) should not be operated on. There are two reasons for this a) There is no reliable research to suggest that this practice benefits patients b) Patients who do have healthy wisdom teeth removed are being exposed to the risks of surgery. These can include: nerve damage damage to other teeth infection bleeding and, rarely, death Also, after surgery to remove wisdom teeth, patients may: have swelling and pain be unable to open their mouth fully 2. Patients who have impacted wisdom teeth that are not causing problems should visit their dentist for their usual check-ups. 3. Only patients, who have diseased wisdom teeth, or other problems with their mouth, should have their wisdom teeth removed. Your dentist or oral surgeon will be aware of the sort of disease or condition which would require you to have surgery. Examples include: untreatable tooth decay abscesses cysts or tumours disease of the tissues around the tooth if the tooth is in the way of other surgery Page 16 of

What should I do? If you or a member of your family or someone you care for are having problems with their wisdom teeth you should discuss this with your dentist or surgeon. Will NICE review its guidance? Yes. The guidance will be reviewed in March 2003. There is further research underway in this area. The results of this will be reviewed by NICE to decide if this guidance needs to be updated before 2003. Further information Further information on NICE, and the full guidance issued to the NHS, is available on the NICE website. Page 17 of

Changes after publication March 2014: minor maintenance March 2012: minor maintenance Page 18 of

About this guidance NICE technology appraisal guidance is about the use of new and existing medicines and treatments in the NHS in England and Wales. Tools to help you put the guidance into practice and information about the evidence it is based on are also available. Your responsibility This guidance represents the views of NICE and was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer. Implementation of this guidance is the responsibility of local commissioners and/or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance, in their local context, in light of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. Nothing in this guidance should be interpreted in a way which would be inconsistent with compliance with those duties. Copyright National Institute for Health and Clinical Excellence 2000. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE. Page of